Namwiwat Medical Corporation PCL (BKK:NAM)

BKK:NAM Financials Overview

Financials in millions THB. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	1,688	1,870	1,114	1,101	1,100	995.36
Revenue Growth	4.61%	67.79%	1.24%	0.04%	10.55%	46.63%
Gross Profit Gross Profit Growth	511.72	540.57	467.87	480.05	327.45	340.63
Operating Income Operating Income Growth	107.55	155.9	212.33	249.9	224.06	225.45
Net Income Net Income Growth	81.33	101.59	180.87	200.75	175.71	174.65
Earnings Per Share EPS Growth	0.12	0.15	0.26	0.33	6.68	8.73
EPS Growth	-54.82%	-43.83%	-20.90%	-95.11%	-23.46%	56.17%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Manufacturing and Distribution of Medical Equipment Manufacturing and Distribution of Medical Equipment Growth	1,019	1,211	628.42	668.66	590.65	629.83
Manufacture and Distribute of Medical Supplies Manufacture and Distribute of Medical Supplies Growth	370.94	365.28	303.88	249.01	296.42	227.42
CSSD Sterilization Services, Medical Equipment Maintenance Services and Infectious Waste Services (SV) CSSD Sterilization Services, Medical Equipment Maintenance Services and Infectious Waste Services (SV) Growth	310.6	286.07	176.03	152.7	-	-
Others Others Growth	6.64	7.74	6.06	4.62	-	-
Total Total Growth	1,688	1,870	1,114	1,101	887.07	857.25

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	687.8	698.78	980.78	1,099	359.6	40.86
Total Debt Total Debt Growth	472.03	495.31	349.8	231.35	263.27	374.89
Net Cash (Debt) Net Cash Growth	215.77	203.47	630.98	867.22	96.34	-334.03
Net Cash Growth	-14.62%	-67.75%	-27.24%	800.18%	-	-
Net Cash Per Share Net Cash Per Share Growth	0.31	0.29	0.90	1.41	3.66	-16.70

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	72.8	37.86	22.94	258.68	-81.16	93.61
Capital Expenditures CapEx Growth	-35.06	-42.79	-55.57	-30.41	-	-
Free Cash Flow Free Cash Flow Growth	37.74	-4.94	-32.64	228.27	-81.16	93.61
Free Cash Flow Growth	149.39%	-	-	-	-	-10.60%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	30.31%	28.91%	41.98%	43.61%	29.76%	34.22%
Operating Margin	6.37%	8.34%	19.05%	22.70%	20.36%	22.65%
Pretax Margin	6.46%	7.98%	20.81%	22.74%	20.17%	21.48%
Profit Margin	4.82%	5.43%	16.23%	18.24%	15.97%	17.55%
FCF Margin	2.23%	-0.26%	-2.93%	20.74%	-7.38%	9.40%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Nov 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.130	0.130	0.150	0.090
Dividend Per Share Growth	-13.33%	-13.33%	66.67%	-
Dividend Yield	4.39%	3.71%	3.26%	1.29%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 9, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	25.48	24.12	17.80	24.23	-	-
Forward PE	-	13.76	13.76	17.38	-	-
P/FCF Ratio	54.90	-	-	21.31	-	-
PS Ratio	1.23	1.31	2.89	4.42	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error